Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Alignment Healthcare Inc., 3 years.
Alignment Healthcare Inc.
Director
TriNet Group Inc.
Director
Royalty Pharma plc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alignment Healthcare Inc. June 4, 202660.8%
-
Royalty Pharma plc June 4, 202698.4%
-
TriNet Group Inc. May 27, 202696.2%
-
Royalty Pharma plc May 12, 202597.6%
-
Royalty Pharma plc June 6, 202497.6%
-
Royalty Pharma plc June 22, 202397.5%
-
Alignment Healthcare Inc. June 6, 202388.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Royalty Pharma plc | Grant or award | +4,545 | — | — |
| May 28, 2026 | TriNet Group Inc. | Grant or award | +7,378 | — | — |
| Mar 13, 2026 | Alignment Healthcare Inc. | Grant or award | +18,982 | — | — |
| May 23, 2025 | TriNet Group Inc. | Grant or award | +4,127 | — | — |
| May 13, 2025 | Royalty Pharma plc | Grant or award | +7,614 | — | — |
| Mar 13, 2025 | Alignment Healthcare Inc. | Grant or award | +18,710 | — | — |
| Oct 4, 2024 | TriNet Group Inc. | Grant or award | +186 | — | — |
| Jun 7, 2024 | Royalty Pharma plc | Grant or award | +9,293 | — | — |
| May 24, 2024 | TriNet Group Inc. | Grant or award | +2,930 | — | — |
| Mar 13, 2024 | Alignment Healthcare Inc. | Grant or award | +50,000 | — | — |
| Jun 23, 2023 | Royalty Pharma plc | Grant or award | +7,747 | — | — |
| May 3, 2023 | TriNet Group Inc. | Gift | −79,891 | — | — |
| Mar 23, 2023 | TriNet Group Inc. | Grant or award | +4,112 | — | — |
| Mar 8, 2023 | Alignment Healthcare Inc. | Grant or award | +36,337 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.